Document ID: chunk:federal_register_of_legislation:C2023A00010:clause:12_32
Version: federal_register_of_legislation:C2023A00010
Segment Type: clause
Provision Reference: sch 12 cl 32
Character Range: 51403–53962

32  Application and saving provisions
(1) The amendments of section 3C of the Therapeutic Goods Act 1989 made by this Schedule apply in relation to determinations made on or after the commencement of this item.
(2) Subsection 26BF(6) of the Therapeutic Goods Act 1989, as added by this Schedule, applies in relation to determinations made under subsection 26BF(1) of that Act on or after the commencement of this item.
(3) Subsection 28(2AA) of the Therapeutic Goods Act 1989, as inserted by this Schedule, applies in relation to determinations made under subsection 28(2) of that Act on or after the commencement of this item.
(4) Paragraph 32BF(6)(ca) of the Therapeutic Goods Act 1989, as inserted by this Schedule, applies in relation to supplies occurring on or after the commencement of this item.
(5) The repeal and substitution of subsection 32CM(4) of the Therapeutic Goods Act 1989 made by this Schedule applies in relation to authorities given on or after the commencement of this item.
(6) The repeal and substitution of subsection 32CM(4) of the Therapeutic Goods Act 1989 made by this Schedule does not affect the continuity of regulations that were made for the purposes of paragraph 32CM(4)(a) or subsection 32CM(4) of that Act and were in force immediately before the commencement of this item.
(7) Subsection 36(5) of the Therapeutic Goods Act 1989, as added by this Schedule, applies in relation to manufacturing principles determined on or after the commencement of this item.
(8) The amendments of subsection 41BD(3) and section 60 of the Therapeutic Goods Act 1989 made by this Schedule apply in relation to declarations made on or after the commencement of this item.
(9) A declaration that was in force under subsection 41BD(3) of the Therapeutic Goods Act 1989 immediately before the commencement of this item continues in force (and may be dealt with) on and after that commencement as if it had been made under that subsection as amended by this Schedule.
(10) The repeal and substitution of subsections 57(10) to (11) of the Therapeutic Goods Act 1989 made by this Schedule does not affect the validity of a delegation that was in force immediately before the commencement of this item.
(11) Subsection 61(9) of the Therapeutic Goods Act 1989, as inserted by this Schedule, applies in relation to an instrument made under subsection 61(5AB) or (5D) of that Act on or after the commencement of this item.

[Minister's second reading speech made in—
House of Representatives on 1 December 2022
Senate on 9 February 2023]

(128/22)